You are here

Judicial review and the life sciences and health sectors

26 February 2021 | UK
Legal Briefings – By Andrew Lidbetter and Sanam Zulfiqar Khan

Share

The life sciences and healthcare sector is subject to complex regulation, and decisions of Government bodies can have a significant impact on the availability and production of pharmaceutical products.

Where Government bodies take decisions of this nature, and there is no other recourse available, judicial review provides an avenue to healthcare companies and others to challenge Government decisions. In a recent publication, we explored judicial review in England and Wales in the life sciences and healthcare sector. In our analysis we considered the various grounds of judicial review, the application of these grounds to specific cases in the healthcare sector and some particular considerations to be taken into account when making a judicial review application.

Download the full article


 

Originally published in Practical Law Magazine, 8 February 2021

See how we help our clients in

Pharmaceuticals and Healthcare

Learn More

Key Contacts